Steven Cohen’s InspireMD NSPR Stock Holding History

Steven Cohen’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-219,093	Closed	-$716K	–	2604
2023 Q3	$716K	Buy	+219,093	New	+$700K	﹤0.01%	1428

Other funds holding NSPR

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Steven Cohen's NSPR Position: Q4 2023 in Review

Steven Cohen sold out of InspireMD (NSPR) in Q4 2023, closing a stake of 219,093 shares — an estimated $716K sold.

Steven Cohen first reported a position in NSPR in Q3 2023 and held it in 1 quarter. The position peaked at $716K in Q3 2023. 29 funds tracked by Wall St. Rank hold NSPR as of Q4 2023.

Steven Cohen reported no remaining InspireMD position as of Q4 2023 after selling out during the quarter.
Steven Cohen sold 219,093 InspireMD shares in Q4 2023, an estimated $716K.
Steven Cohen first reported a position in InspireMD in Q3 2023 and held it in 1 quarter.
Steven Cohen's InspireMD position peaked at $716K in Q3 2023.
29 funds tracked by Wall St. Rank held InspireMD as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.